Global Monoclonal Antibody ADC Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Monoclonal Antibody ADC Drugs Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody ADC Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody ADC Drugs sales for 2023 through 2029. With Monoclonal Antibody ADC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody ADC Drugs industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody ADC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody ADC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monoclonal Antibody ADC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody ADC Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody ADC Drugs.
The global Monoclonal Antibody ADC Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Monoclonal Antibody ADC Drugs players cover Seattle, Roche, Pfizer, AstraZeneca, Immunomedics, GSK and ADC Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody ADC Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Monoclonal Antibody ADC Drugs market?
What factors are driving Monoclonal Antibody ADC Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monoclonal Antibody ADC Drugs market opportunities vary by end market size?
How does Monoclonal Antibody ADC Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Monoclonal Antibody ADC Drugs Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody ADC Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody ADC Drugs sales for 2023 through 2029. With Monoclonal Antibody ADC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody ADC Drugs industry.
This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody ADC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody ADC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monoclonal Antibody ADC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody ADC Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody ADC Drugs.
The global Monoclonal Antibody ADC Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Monoclonal Antibody ADC Drugs players cover Seattle, Roche, Pfizer, AstraZeneca, Immunomedics, GSK and ADC Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody ADC Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- CD30 Target Antigen
- HER2 Target Antigen
- CD22 Target Antigen
- CD33 Target Antigen
- Nectin-4 Target Antigen
- Others
- Lymphoma
- Breast Cancer
- Leukemia
- Myeloma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seattle
- Roche
- Pfizer
- AstraZeneca
- Immunomedics
- GSK
- ADC Therapeutics
What is the 10-year outlook for the global Monoclonal Antibody ADC Drugs market?
What factors are driving Monoclonal Antibody ADC Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monoclonal Antibody ADC Drugs market opportunities vary by end market size?
How does Monoclonal Antibody ADC Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Country/Region, 2018, 2022 & 2029
2.2 Monoclonal Antibody ADC Drugs Segment by Type
2.2.1 CD30 Target Antigen
2.2.2 HER2 Target Antigen
2.2.3 CD22 Target Antigen
2.2.4 CD33 Target Antigen
2.2.5 Nectin-4 Target Antigen
2.2.6 Others
2.3 Monoclonal Antibody ADC Drugs Sales by Type
2.3.1 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Type (2018-2023)
2.4 Monoclonal Antibody ADC Drugs Segment by Application
2.4.1 Lymphoma
2.4.2 Breast Cancer
2.4.3 Leukemia
2.4.4 Myeloma
2.4.5 Others
2.5 Monoclonal Antibody ADC Drugs Sales by Application
2.5.1 Global Monoclonal Antibody ADC Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Monoclonal Antibody ADC Drugs Sale Price by Application (2018-2023)
3 GLOBAL MONOCLONAL ANTIBODY ADC DRUGS BY COMPANY
3.1 Global Monoclonal Antibody ADC Drugs Breakdown Data by Company
3.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2018-2023)
3.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Company (2018-2023)
3.2.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibody ADC Drugs Product Location Distribution
3.4.2 Players Monoclonal Antibody ADC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONOCLONAL ANTIBODY ADC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Monoclonal Antibody ADC Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Monoclonal Antibody ADC Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Monoclonal Antibody ADC Drugs Sales Growth
4.4 APAC Monoclonal Antibody ADC Drugs Sales Growth
4.5 Europe Monoclonal Antibody ADC Drugs Sales Growth
4.6 Middle East & Africa Monoclonal Antibody ADC Drugs Sales Growth
5 AMERICAS
5.1 Americas Monoclonal Antibody ADC Drugs Sales by Country
5.1.1 Americas Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
5.1.2 Americas Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
5.2 Americas Monoclonal Antibody ADC Drugs Sales by Type
5.3 Americas Monoclonal Antibody ADC Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody ADC Drugs Sales by Region
6.1.1 APAC Monoclonal Antibody ADC Drugs Sales by Region (2018-2023)
6.1.2 APAC Monoclonal Antibody ADC Drugs Revenue by Region (2018-2023)
6.2 APAC Monoclonal Antibody ADC Drugs Sales by Type
6.3 APAC Monoclonal Antibody ADC Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Monoclonal Antibody ADC Drugs by Country
7.1.1 Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
7.1.2 Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
7.2 Europe Monoclonal Antibody ADC Drugs Sales by Type
7.3 Europe Monoclonal Antibody ADC Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody ADC Drugs by Country
8.1.1 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type
8.3 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs
10.3 Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
10.4 Industry Chain Structure of Monoclonal Antibody ADC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monoclonal Antibody ADC Drugs Distributors
11.3 Monoclonal Antibody ADC Drugs Customer
12 WORLD FORECAST REVIEW FOR MONOCLONAL ANTIBODY ADC DRUGS BY GEOGRAPHIC REGION
12.1 Global Monoclonal Antibody ADC Drugs Market Size Forecast by Region
12.1.1 Global Monoclonal Antibody ADC Drugs Forecast by Region (2024-2029)
12.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Monoclonal Antibody ADC Drugs Forecast by Type
12.7 Global Monoclonal Antibody ADC Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Seattle
13.1.1 Seattle Company Information
13.1.2 Seattle Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.1.3 Seattle Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Seattle Main Business Overview
13.1.5 Seattle Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.2.3 Roche Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.3.3 Pfizer Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Immunomedics
13.5.1 Immunomedics Company Information
13.5.2 Immunomedics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.5.3 Immunomedics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Immunomedics Main Business Overview
13.5.5 Immunomedics Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.6.3 GSK Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 ADC Therapeutics
13.7.1 ADC Therapeutics Company Information
13.7.2 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ADC Therapeutics Main Business Overview
13.7.5 ADC Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Country/Region, 2018, 2022 & 2029
2.2 Monoclonal Antibody ADC Drugs Segment by Type
2.2.1 CD30 Target Antigen
2.2.2 HER2 Target Antigen
2.2.3 CD22 Target Antigen
2.2.4 CD33 Target Antigen
2.2.5 Nectin-4 Target Antigen
2.2.6 Others
2.3 Monoclonal Antibody ADC Drugs Sales by Type
2.3.1 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Type (2018-2023)
2.4 Monoclonal Antibody ADC Drugs Segment by Application
2.4.1 Lymphoma
2.4.2 Breast Cancer
2.4.3 Leukemia
2.4.4 Myeloma
2.4.5 Others
2.5 Monoclonal Antibody ADC Drugs Sales by Application
2.5.1 Global Monoclonal Antibody ADC Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Monoclonal Antibody ADC Drugs Sale Price by Application (2018-2023)
3 GLOBAL MONOCLONAL ANTIBODY ADC DRUGS BY COMPANY
3.1 Global Monoclonal Antibody ADC Drugs Breakdown Data by Company
3.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2018-2023)
3.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Company (2018-2023)
3.2.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibody ADC Drugs Product Location Distribution
3.4.2 Players Monoclonal Antibody ADC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONOCLONAL ANTIBODY ADC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Monoclonal Antibody ADC Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Monoclonal Antibody ADC Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Monoclonal Antibody ADC Drugs Sales Growth
4.4 APAC Monoclonal Antibody ADC Drugs Sales Growth
4.5 Europe Monoclonal Antibody ADC Drugs Sales Growth
4.6 Middle East & Africa Monoclonal Antibody ADC Drugs Sales Growth
5 AMERICAS
5.1 Americas Monoclonal Antibody ADC Drugs Sales by Country
5.1.1 Americas Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
5.1.2 Americas Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
5.2 Americas Monoclonal Antibody ADC Drugs Sales by Type
5.3 Americas Monoclonal Antibody ADC Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody ADC Drugs Sales by Region
6.1.1 APAC Monoclonal Antibody ADC Drugs Sales by Region (2018-2023)
6.1.2 APAC Monoclonal Antibody ADC Drugs Revenue by Region (2018-2023)
6.2 APAC Monoclonal Antibody ADC Drugs Sales by Type
6.3 APAC Monoclonal Antibody ADC Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Monoclonal Antibody ADC Drugs by Country
7.1.1 Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
7.1.2 Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
7.2 Europe Monoclonal Antibody ADC Drugs Sales by Type
7.3 Europe Monoclonal Antibody ADC Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Monoclonal Antibody ADC Drugs by Country
8.1.1 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type
8.3 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs
10.3 Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
10.4 Industry Chain Structure of Monoclonal Antibody ADC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monoclonal Antibody ADC Drugs Distributors
11.3 Monoclonal Antibody ADC Drugs Customer
12 WORLD FORECAST REVIEW FOR MONOCLONAL ANTIBODY ADC DRUGS BY GEOGRAPHIC REGION
12.1 Global Monoclonal Antibody ADC Drugs Market Size Forecast by Region
12.1.1 Global Monoclonal Antibody ADC Drugs Forecast by Region (2024-2029)
12.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Monoclonal Antibody ADC Drugs Forecast by Type
12.7 Global Monoclonal Antibody ADC Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Seattle
13.1.1 Seattle Company Information
13.1.2 Seattle Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.1.3 Seattle Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Seattle Main Business Overview
13.1.5 Seattle Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.2.3 Roche Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.3.3 Pfizer Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Immunomedics
13.5.1 Immunomedics Company Information
13.5.2 Immunomedics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.5.3 Immunomedics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Immunomedics Main Business Overview
13.5.5 Immunomedics Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.6.3 GSK Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 ADC Therapeutics
13.7.1 ADC Therapeutics Company Information
13.7.2 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
13.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ADC Therapeutics Main Business Overview
13.7.5 ADC Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of CD30 Target Antigen
Table 4. Major Players of HER2 Target Antigen
Table 5. Major Players of CD22 Target Antigen
Table 6. Major Players of CD33 Target Antigen
Table 7. Major Players of Nectin-4 Target Antigen
Table 8. Major Players of Others
Table 9. Global Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Monoclonal Antibody ADC Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Monoclonal Antibody ADC Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Monoclonal Antibody ADC Drugs Revenue by Application (2018-2023)
Table 17. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Monoclonal Antibody ADC Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Monoclonal Antibody ADC Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Monoclonal Antibody ADC Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution and Sales Area
Table 25. Players Monoclonal Antibody ADC Drugs Products Offered
Table 26. Monoclonal Antibody ADC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Monoclonal Antibody ADC Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Monoclonal Antibody ADC Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Monoclonal Antibody ADC Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Monoclonal Antibody ADC Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Monoclonal Antibody ADC Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Monoclonal Antibody ADC Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Monoclonal Antibody ADC Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Monoclonal Antibody ADC Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Monoclonal Antibody ADC Drugs
Table 62. Key Market Challenges & Risks of Monoclonal Antibody ADC Drugs
Table 63. Key Industry Trends of Monoclonal Antibody ADC Drugs
Table 64. Monoclonal Antibody ADC Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Monoclonal Antibody ADC Drugs Distributors List
Table 67. Monoclonal Antibody ADC Drugs Customer List
Table 68. Global Monoclonal Antibody ADC Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Monoclonal Antibody ADC Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Monoclonal Antibody ADC Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Monoclonal Antibody ADC Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Seattle Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Seattle Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 84. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Seattle Main Business
Table 86. Seattle Latest Developments
Table 87. Roche Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 89. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Pfizer Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 94. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. AstraZeneca Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 99. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Immunomedics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Immunomedics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 104. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Immunomedics Main Business
Table 106. Immunomedics Latest Developments
Table 107. GSK Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. GSK Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 109. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. GSK Main Business
Table 111. GSK Latest Developments
Table 112. ADC Therapeutics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 114. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. ADC Therapeutics Main Business
Table 116. ADC Therapeutics Latest Developments
Table 1. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of CD30 Target Antigen
Table 4. Major Players of HER2 Target Antigen
Table 5. Major Players of CD22 Target Antigen
Table 6. Major Players of CD33 Target Antigen
Table 7. Major Players of Nectin-4 Target Antigen
Table 8. Major Players of Others
Table 9. Global Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Monoclonal Antibody ADC Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Monoclonal Antibody ADC Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Monoclonal Antibody ADC Drugs Revenue by Application (2018-2023)
Table 17. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Monoclonal Antibody ADC Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Monoclonal Antibody ADC Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Monoclonal Antibody ADC Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution and Sales Area
Table 25. Players Monoclonal Antibody ADC Drugs Products Offered
Table 26. Monoclonal Antibody ADC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Monoclonal Antibody ADC Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Monoclonal Antibody ADC Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Monoclonal Antibody ADC Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Monoclonal Antibody ADC Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Monoclonal Antibody ADC Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Monoclonal Antibody ADC Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Monoclonal Antibody ADC Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Monoclonal Antibody ADC Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Monoclonal Antibody ADC Drugs
Table 62. Key Market Challenges & Risks of Monoclonal Antibody ADC Drugs
Table 63. Key Industry Trends of Monoclonal Antibody ADC Drugs
Table 64. Monoclonal Antibody ADC Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Monoclonal Antibody ADC Drugs Distributors List
Table 67. Monoclonal Antibody ADC Drugs Customer List
Table 68. Global Monoclonal Antibody ADC Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Monoclonal Antibody ADC Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Monoclonal Antibody ADC Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Monoclonal Antibody ADC Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Seattle Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Seattle Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 84. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Seattle Main Business
Table 86. Seattle Latest Developments
Table 87. Roche Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 89. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Pfizer Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 94. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. AstraZeneca Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 99. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Immunomedics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Immunomedics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 104. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Immunomedics Main Business
Table 106. Immunomedics Latest Developments
Table 107. GSK Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. GSK Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 109. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. GSK Main Business
Table 111. GSK Latest Developments
Table 112. ADC Therapeutics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Portfolios and Specifications
Table 114. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. ADC Therapeutics Main Business
Table 116. ADC Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Monoclonal Antibody ADC Drugs
Figure 2. Monoclonal Antibody ADC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibody ADC Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Monoclonal Antibody ADC Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Monoclonal Antibody ADC Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of CD30 Target Antigen
Figure 10. Product Picture of HER2 Target Antigen
Figure 11. Product Picture of CD22 Target Antigen
Figure 12. Product Picture of CD33 Target Antigen
Figure 13. Product Picture of Nectin-4 Target Antigen
Figure 14. Product Picture of Others
Figure 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type in 2022
Figure 16. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Monoclonal Antibody ADC Drugs Consumed in Lymphoma
Figure 18. Global Monoclonal Antibody ADC Drugs Market: Lymphoma (2018-2023) & (K Units)
Figure 19. Monoclonal Antibody ADC Drugs Consumed in Breast Cancer
Figure 20. Global Monoclonal Antibody ADC Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 21. Monoclonal Antibody ADC Drugs Consumed in Leukemia
Figure 22. Global Monoclonal Antibody ADC Drugs Market: Leukemia (2018-2023) & (K Units)
Figure 23. Monoclonal Antibody ADC Drugs Consumed in Myeloma
Figure 24. Global Monoclonal Antibody ADC Drugs Market: Myeloma (2018-2023) & (K Units)
Figure 25. Monoclonal Antibody ADC Drugs Consumed in Others
Figure 26. Global Monoclonal Antibody ADC Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2022)
Figure 28. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application in 2022
Figure 29. Monoclonal Antibody ADC Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Monoclonal Antibody ADC Drugs Sales Market Share by Company in 2022
Figure 31. Monoclonal Antibody ADC Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company in 2022
Figure 33. Global Monoclonal Antibody ADC Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 44. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2022
Figure 52. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 63. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs in 2022
Figure 81. Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
Figure 82. Industry Chain Structure of Monoclonal Antibody ADC Drugs
Figure 83. Channels of Distribution
Figure 84. Global Monoclonal Antibody ADC Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Monoclonal Antibody ADC Drugs
Figure 2. Monoclonal Antibody ADC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibody ADC Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Monoclonal Antibody ADC Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Monoclonal Antibody ADC Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of CD30 Target Antigen
Figure 10. Product Picture of HER2 Target Antigen
Figure 11. Product Picture of CD22 Target Antigen
Figure 12. Product Picture of CD33 Target Antigen
Figure 13. Product Picture of Nectin-4 Target Antigen
Figure 14. Product Picture of Others
Figure 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type in 2022
Figure 16. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Monoclonal Antibody ADC Drugs Consumed in Lymphoma
Figure 18. Global Monoclonal Antibody ADC Drugs Market: Lymphoma (2018-2023) & (K Units)
Figure 19. Monoclonal Antibody ADC Drugs Consumed in Breast Cancer
Figure 20. Global Monoclonal Antibody ADC Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 21. Monoclonal Antibody ADC Drugs Consumed in Leukemia
Figure 22. Global Monoclonal Antibody ADC Drugs Market: Leukemia (2018-2023) & (K Units)
Figure 23. Monoclonal Antibody ADC Drugs Consumed in Myeloma
Figure 24. Global Monoclonal Antibody ADC Drugs Market: Myeloma (2018-2023) & (K Units)
Figure 25. Monoclonal Antibody ADC Drugs Consumed in Others
Figure 26. Global Monoclonal Antibody ADC Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2022)
Figure 28. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application in 2022
Figure 29. Monoclonal Antibody ADC Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Monoclonal Antibody ADC Drugs Sales Market Share by Company in 2022
Figure 31. Monoclonal Antibody ADC Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company in 2022
Figure 33. Global Monoclonal Antibody ADC Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Monoclonal Antibody ADC Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 44. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2022
Figure 52. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 63. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Monoclonal Antibody ADC Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs in 2022
Figure 81. Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
Figure 82. Industry Chain Structure of Monoclonal Antibody ADC Drugs
Figure 83. Channels of Distribution
Figure 84. Global Monoclonal Antibody ADC Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Application (2024-2029)
